Jornada- La problemática del fentanilo

The video provides a comprehensive and nuanced discussion of the fentanyl problem, focusing on the Spanish context while acknowledging the US crisis. The speakers are highly qualified: Dr. Pérez Hernández is a pain specialist with extensive clinical experience, and Professor Rubio is a psychiatrist specializing in addiction. Their presentations are evidence-based, referencing meta-analyses and epidemiological data. The argumentation is solid, emphasizing the importance of a biopsychosocial approach to chronic pain and the careful use of opioids. The discussion is balanced, acknowledging both the benefits and risks of opioid therapy, including tolerance, dependence, and endocrine side effects. The speakers also address the role of the healthcare system in preventing a crisis, highlighting the current low prevalence of non-medical fentanyl use in Spain compared to the US. However, the video is a recording of a conference, so the production quality is typical of such events, with occasional audio issues. The content is highly informative for a professional audience, but may be too technical for the general public. The sources cited are primarily clinical guidelines and meta-analyses, but specific references are not always provided on screen. The title accurately reflects the content, and the discussion is well-structured. Overall, this is a valuable resource for healthcare professionals and policymakers interested in opioid stewardship and addiction prevention.

The title accurately reflects the content, which is a conference on the fentanyl problem, covering medical use, addiction, and public health perspectives.

8/10

The video features recognized experts in pharmacology, pain management, and psychiatry, providing a balanced and evidence-based discussion. The content is well-structured, references meta-analyses, and offers a comprehensive view of the fentanyl problem in Spain, with appropriate caveats and data. Minor limitations include the lack of detailed citations for some claims and the absence of a formal Q&A transcript.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction by the moderator, Juan Tamargo, outlining the objectives of the conference.
• 05:00Dr. Pérez Hernández begins her presentation on opioids and chronic pain, providing epidemiological data on pain in Spain.
• 10:00Discussion of the types of pain (nociceptive, neuropathic, nociplastic) and their treatment approaches.
• 15:00Explanation of the role of opioids in chronic pain management, including their efficacy and side effects.
• 20:00Professor Rubio discusses the psychiatric aspects of opioid use disorder and the risk factors for addiction.
• 30:00Comparison between the US fentanyl crisis and the situation in Spain, highlighting protective factors.
• 40:00Q&A session begins, with audience questions on pain unit availability and opioid prescribing practices.
• 50:00Discussion on the role of the pharmaceutical industry and the importance of prevention strategies.
• 1:00:00Concluding remarks and summary of key takeaways.

• Fundación Ramón Areces — Organizer of the conference and source of the video.

• WHO Model List of Essential Medicines — Fentanyl is listed as an essential medicine, supporting its medical use.

• US CDC reports on fentanyl crisis